We therefore investigated the effect of GANT61 and AURKA inhibitor MK-0457 in M07e and WSU-AML cell lines carrying the CBFA2T3-GLIS2 fusion gene. This evidence concerns the gene GLIS2 and acute myeloid leukemia.